Location
Headquarters: Parsippany, New Jersey, United States, North America
Region: New Jersey
Country: US
Continent: North America
About
Zoetis is a global animal health company focused on advancing care for animals. Its portfolio includes medicines, vaccines, diagnostics, biodevices, genetic tests, and precision livestock farming technologies, serving veterinarians, livestock producers, pet owners, and broader animal-health ecosystems across more than 100 countries. The company emphasizes research-driven solutions to predict, prevent, detect, and treat diseases in pets and livestock. Headquartered in the United States, Zoetis operates worldwide with a commitment to sustainability and the human-animal bond.
Zoetis discovers, develops, manufactures, and commercializes medicines, vaccines, diagnostics, and digital solutions for companion animals and livestock. The company serves veterinarians, livestock producers, and pet owners across more than 100 countries to prevent, detect, and treat animal diseases. It operates as an independent entity focused on advancing animal health through research-driven in
Zoetis Services LLC
2013
for_profit
active
Industries
Primary Industry: Business Services
Categories
Funding & Financials
Public Company
6400000000
over-1b
ipo
NYSE:ZTS
nasdaq
Investors
Leadership
Joakim Rodin — Senior Technology Project Manager
Kristin Peck — Chief Executive Officer
Chitra Varma — Head of Data & Analytic Engineering
Mark Davies — Senior Director, Head of Digital and Multi Channel Marketing (International)
Matthew Petersen — Veterinary Operations Manager
Meredith Ferguson — Corporate Brand and Digital Strategy & Operations Lead
Keith Schleicher — Head of Enterprise Data Science
Technology Stack
Products
Draxxin KP (tulathromycin and ketoprofen injection) Injectable Solution: An injectable solution combining tulathromycin and ketoprofen for treatment of respiratory diseases and inflammation in beef and dairy cattle.
Simparica TRIO: A chewable tablet for dogs that protects against fleas, ticks, and heartworm disease.
Apoquel (oclacitinib tablet) / Apoquel Chewable (oclacitinib chewable tablet): Oral tablets for dogs that manage itching and inflammation associated with allergic skin conditions.
Librela: A treatment for dogs to manage osteoarthritis pain and improve mobility.
CYTOPOINT: An injectable treatment for dogs that targets and controls allergic skin disease symptoms.
Solensia: An injectable treatment for cats to manage osteoarthritis pain and improve joint function.
Funding rounds
Post Ipo Debt · $1.75B · (2025-12-16)
Post Ipo Debt · $1.85B · (2025-08-11)
Grant · $15.3M · (2023-03-01) · Lead: Bill & Melinda Gates Foundation